SCHEMBL29892274

SCHEMBL29892274

c1ccc(Nc2ccc(-n3c4ccccc4c4ccccc43)cc2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.65
ATM Q13315 3/20 0.65
KDM4E B2RXH2 2/20 0.65
ALDH1A1 P00352 8/20 0.52
HSD17B10 Q99714 6/20 0.52
TDP1 Q9NUW8 4/20 0.52
TSHR P16473 4/20 0.52
ALOX12 P18054 3/20 0.52
ALOX15 P16050 3/20 0.52
PTGS1 P23219 1/20 0.52
SLC6A2 P23975 1/20 0.52
MAPK1 P28482 1/20 0.52
PTGS2 P35354 1/20 0.52
HTR2B P41595 1/20 0.52
HSP90AA1 P07900 1/20 0.47
CYP3A4 P08684 5/20 0.43
MAPT P10636 3/20 0.43
HPGD P15428 3/20 0.43
HTT P42858 2/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL275113 1.00 L3MBTL1 (0.65) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL31685953 1.00 L3MBTL1 (0.65) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL13301619 1.00 L3MBTL1 (0.65) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL30476140 0.96 L3MBTL1 (0.64) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL10307238 0.96 L3MBTL1 (0.64) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL23423723 0.94 L3MBTL1 (0.59) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL490305 0.94 L3MBTL1 (0.59) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL23423503 0.91 L3MBTL1 (0.59) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL12249880 0.91 L3MBTL1 (0.59) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL23310448 0.91 L3MBTL1 (0.59) L3MBTL1ATMKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359452-A1 DISPLAY DEVICE SEMICONDUCTOR ENERGY LAB (JP) 2025-11-20 US disclosed
US-20250250483-A1 ORGANOMETALLIC COMPLEX AND LIGHT-EMITTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-08-07 US disclosed
US-20250204142-A1 Light-Emitting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-06-19 US disclosed
CN-120166858-A Light emitting device 株式会社半导体能源研究所 2025-06-17 CN disclosed
CN-119451453-A Display device 株式会社半导体能源研究所 2025-02-14 CN disclosed
US-20250040388-A1 DISPLAY DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-01-30 US disclosed
US-20250034177-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-01-30 US disclosed
CN-119264174-A Organic compound, light-emitting device, light-emitting apparatus, electronic device, and lighting apparatus 株式会社半导体能源研究所 2025-01-07 CN disclosed
CN-117044428-A Lateral current suppressing material, carbazole compound, hole injection layer, and organic electroluminescent element 东曹株式会社 2023-11-10 CN disclosed
WO-2022211123-A1 TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE INJECTION LAYER, AND ORGANIC ELECTROLUMINESCENT ELEMENT 東ソー株式会社 2022-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250034177-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device CRY1, CCT5, C1S L3MBTL1 60/4885ATM 3006/4885KDM4E 2475/4885
US-20250250483-A1 ORGANOMETALLIC COMPLEX AND LIGHT-EMITTING DEVICE CRY1, CRY2, RPS23 L3MBTL1 251/4885ATM 2507/4885KDM4E 3513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.